MWM
IMNM icon

Maltin Wealth Management’s Immunome IMNM Stock Holding History

Maltin Wealth Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Buy
+15,000
New +$334K 0.13% 99

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Maltin Wealth Management's IMNM Position: Q1 2026 in Review

Maltin Wealth Management opened a new position in Immunome (IMNM) in Q1 2026: 15,000 shares worth $328K. The stake represents 0.13% of the portfolio and ranks #99 among its holdings.

200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Maltin Wealth Management held 15,000 shares of Immunome worth $328K as of Q1 2026.
  • Immunome was a new Maltin Wealth Management position in Q1 2026.
  • Immunome made up 0.13% of Maltin Wealth Management's portfolio in Q1 2026, its #99 holding.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Maltin Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.